News
Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is ...
In the wake of mass restructuring efforts across the Department of Health and Human Services, the FDA has missed yet another ...
During his first term, attempts by President Donald Trump to slash drug price | After failing in his first term to install a ...
The FDA’s Oncologic Drugs Advisory Committee (ODAC) is planning to host its first meeting under new agency commissioner Marty ...
Takeda was scrambling to accommodate for rapidly sinking profits from the hasty decline of ADHD mainstay Vyvanse with a 140 ...
Amneal Pharmaceuticals inked a collaboration deal with syringe maker Apiject that will see the New Jersey-based biopharma ...
Another Big Pharma is opening up its wallet to pour billions into its U.S. operations amid political pressure from the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results